OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for HyHubTM and HyHubTM Duo, devices for patients 17 years of age and older that allow HYQVIA® [Immune Globulin Infusion (Human), 10% with Recombinant Human Hyaluronidase] to be transferred from vials without using a needle in a home environment or clinical setting.2 The HYQVIA administration process consists of dual vial unit.

SEATTLE--(BUSINESS WIRE)--New listings of U.S. homes for sale fell 3.2% in June to the lowest seasonally-adjusted level since October 2023, according to a new report from Redfin, the real estate brokerage powered by Rocket. That's the biggest month-over-month decline since February 2023. New listings fell 3.4% year over year, the first annual decline since October 2023. Active listings—the total number of homes for sale—fell 0.3% month over month in June. That's the first decline since July 202.

BERKELEY, Calif, July 21, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (NASDAQ: PFSA), a commercial stage digital health company pioneering the next generation of technology platform enabling the continuous monitoring of an individual's biochemistry, today announced that it is initiating a Bitcoin treasury strategy via the execution of a Securities Purchase Agreement (the “ELOC”) with Ascent Partners Fund LLC, (“Ascent”), pursuant to which Ascent will purchase up to $100,000,000 of the Company's Common Stock. 100% of the net proceeds will be used to purchase Bitcoin (which can be used for debt repayment) provided that the Company's cash …

Amid emergency conditions from summer heat and power generation shortfalls, Sunrun answers urgent utility requests to dispatch energy from home batteries to improve grid reliability Amid emergency conditions from summer heat and power generation shortfalls, Sunrun answers urgent utility requests to dispatch energy from home batteries to improve grid reliability

Upexi purchased an additional 100,000 SOL, and anticipates it may generate up to approximately $26 million in annual staking revenue based on current SOL holdings Company releases adjusted metrics for enhanced transparency and analysis

CAMBRIDGE, Mass., July 21, 2025 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company committed to the discovery and development of therapeutic antibodies targeting toxic misfolded proteins in neurodegenerative diseases, such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS) and Parkinson's disease (PD), today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to PMN310, the Company's lead therapeutic candidate in development for the treatment of Alzheimer's disease (AD).

A social-first activation celebrates bold choices and the snack that always delivers. CHICAGO , July 21, 2025 /PRNewswire/ -- Nutri-Grain® is extending its bold new energy beyond the grocery aisle and into pop culture with the launch of Not Sorry — a clever, social-first campaign that brings together three unapologetically iconic reality personalities to celebrate the things we enjoy, without the pressure to explain ourselves.

Building a Global Data-Driven Energy Ecosystem Via Partnerships Aiming to Create a Smarter, Greener, and More Efficient Energy Future SHANGHAI , July 21, 2025 /PRNewswire/ -- U Power Limited (Nasdaq: UCAR) (the "Company" or "U Power"), a provider of AI-powered solutions for next-generation energy grids and intelligent transportation systems, building on its proprietary UOTTATM electric vehicle (EV) battery-swapping technology, today announced the inauguration of Southeast Asia's first operational smart battery-swapping station (the "Thailand Station"), located in Phuket Island, Thailand. The commencement of operations at the Thailand Station follows U Power's May 2025 delivery of Southeast Asia's first battery-swapping compatible taxi …

PALM BEACH GARDENS, Fla., July 21, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (“ZimVie”) (Nasdaq: ZIMV), a global life sciences leader in the dental implant market, today announced their entry into a definitive agreement pursuant to which ZimVie will be acquired by an affiliate of ARCHIMED (“ARCHIMED”), an investment firm focused exclusively on healthcare industries.

RENO, Nev., July 21, 2025 (GLOBE NEWSWIRE) -- Dragonfly Energy Holdings Corp. (“Dragonfly Energy” or the “Company”) (Nasdaq: DFLI), an industry leader in energy storage and battery technology, today announced that it has entered into a Settlement and Mutual Release Agreement (the “Agreement”) with the holder of its Series A Convertible Preferred Stock, par value $0.0001 per share (the “Series A Preferred Stock”), eliminating all outstanding shares of the Series A Preferred Stock and associated common stock issuance obligations. Under the terms of the Agreement, Dragonfly Energy will issue 2,100,000 shares of the Company's common stock, par value $0.0001 per …

Increases Ethereum treasury holdings to approximately $38 million, with recent $30 million purchase Launches NFT yield program creating one of the first treasury management strategies to leverage digital assets within the Ethereum ecosystem targeting an expected annualized return of 6%-10% FRISCO, Texas , July 21, 2025 /PRNewswire/ -- — GameSquare Holdings, Inc. (Nasdaq: GAME) (the "Company" or "GameSquare") a next-generation media, entertainment, and technology company, today announced that its Board of Directors has increased the Company's digital asset treasury management authorization from $100 million to $250 million. As part of the expanded program, the Board has approved a new NFT …

New York, July 21, 2025 (GLOBE NEWSWIRE) -- Mercurity Fintech Holding Inc. (“MFH” or the “Company”) (Nasdaq: MFH), a blockchain-powered fintech group, today announced it has entered into a $200 million Equity Line of Credit Agreement with Solana Ventures Ltd., to launch the Company's Solana-based digital asset treasury strategy.

CAMBRIDGE, Mass., July 21, 2025 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage biopharmaceutical company focused on developing a new class of genetic medicines based on editing RNA for both rare and highly prevalent diseases, announced today that it has been granted orphan drug designation by the European Medicines Agency (EMA) Committee, who adopted a positive opinion on KRRO-110, Korro's investigational medicine for the treatment of Alpha-1 Antitrypsin Deficiency (AATD).

Healthcare REITs have outperformed major indices, but several are now trading at significant premiums to fair value, warranting caution. This article takes a quick look at 5 such companies, with a thumbnail sketch and 9 key metrics. Despite strong growth prospects for some, high price/FFO ratios, elevated premiums to NAV, and dividend safety concerns make these REITs questionable at current prices.

Enrollment in FURVENT was completed in Q1 2025 Firmonertinib received FDA Breakthrough Therapy Designation in this patient population NEWTOWN SQUARE, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc. (Company or ArriVent) (Nasdaq: AVBP), a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today announced that topline firmonertinib monotherapy data from the global pivotal FURVENT Phase 3 (NCT05607550) study in first-line EGFR exon20 insertion mutant non-small cell lung cancer (NSCLC) is projected to be in early 2026.

New York, New York--(Newsfile Corp. - July 21, 2025) - Aeries Technology (NASDAQ: AERT), a global leader in AI-enabled value creation, business transformation, and Global Capability Center (GCC) delivery for private equity portfolio companies, today announced the launch of its AI Partner Network Program . This initiative brings together a select set of agentic AI-native solutions curated to meet the operational needs of mid-market companies backed by private equity.

London, United Kingdom--(Newsfile Corp. - July 21, 2025) - Gorilla Technology Group Inc. (NASDAQ: GRRR) ("Gorilla" or the "Company"), today announced that it has resolved its previously disclosed litigation against Culper Research ("Culper") and its founder, Christian Lamarco. The Company issued the following statement: Subsequent to a report published on April 4, 2025 by Culper Research, Gorilla Technology filed a lawsuit against Culper and its founder, Christian Lamarco, on April 16, 2025.

GLEN ALLEN, Va.--(BUSINESS WIRE)--Dynex Capital, Inc. ("Dynex" or the "Company") (NYSE: DX) reported its second quarter 2025 financial results today. Management will host a call today at 10:00 a.m. Eastern Time to discuss the results and business outlook. Details to access the call can be found below under "Earnings Conference Call." Second Quarter Financial Performance and Other Highlights Total economic loss of $(0.10) per common share, or (0.8)% of beginning book value, comprised of a declin.

MCLEAN, Va.--(BUSINESS WIRE)---- $BAH--Booz Allen Hamilton (NYSE: BAH) announced that it is tripling its venture capital commitment from $100 million to $300 million.

PHOENIX--(BUSINESS WIRE)--Teledyne FLIR Defense, part of Teledyne Technologies Incorporated (NYSE:TDY), announced the winners of the 30th Annual ‘FLIR Vision Awards' at the APSCON 2025 Conference in Phoenix, Arizona. The FLIR Vision Awards are presented to members of the airborne law enforcement community who have best demonstrated use of thermal imaging systems in carrying out their missions, whether conducting search and rescue efforts, pursuing suspects, or saving lives in other ways. The aw.